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Objective: Determine whether Radiofrequency ablation (RFA) of the pancreas and 
subsequent transection of the main pancreatic duct may avoid the risk of both 
necrotizing pancreatitis and postoperative pancreatic fistula (POPF) formation. 
Methods: Thirty-two rats were subjected to RFA and section of the pancreas over their 
portal vein. Animals were killed at 3, 7, 15 and 21 days (Groups 0-3, respectively). Two 
additional control groups (sham operation and user manipulation only, respectively) of 
15 days of postoperative period were considered. Postoperative complications, 
histological changes (including morphometric and immunohistochemical analysis) and 
incidence of POPF were evaluated. 
Results: A significant increase in serum amylase levels (p<0.05) on the 3rd 
postoperative day which return to baseline levels in the following weeks was noted in 
groups 0-3. Those groups showed a rapid atrophy of the distal pancreas by apoptosis 
with no signs of necrotizing pancreatitis or POPF. The distal pancreas in groups 1-3 
compared to group 0 and control groups showed a significant increase of small islets 
(<1000 μm2). 
Conclusions: The rapid acinar atrophy of the distal pancreas after RFA and section of 
the pancreatic ducts in this model does not lead to necrotizing pancreatitis. 
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 It is well known that after ligation of the rat pancreas, acinar cells disappear from the 
distal gland in 5 days with no signs of necrotizing pancreatitis1,2 probably because 
apoptosis of the acinar cells is the leading phenomenon after a completely obstructed 
main pancreatic duct1. However, even though the absence of an anastomosis of the 
pancreatic remnant may prevent many postoperative complications, the occlusion of 
the pancreatic stump with synthetic/biological substances or sutures has not been 
widely accepted due to a high percentage of pancreatic fistula (sometimes more than 
50%) and postoperative collections3. Additionally, an increase risk of exocrine4 and 
endocrine pancreatic insufficiency cannot be ruled out 5. In any case, the risk of a long-
lasting fistula formation is the more cumbersome complication after ligation of the main 
pancreatic duct after pancreaticoduodenectomy (PD)6. 
  Radiofrequency (RF) ablation is a local ablative method that can destroy 
tumors by thermal denaturation of proteins and has been used successfully in the 
treatment of other unresectable tumors in the liver, lung, kidney and bones7.  
Concerning the pancreas, given that most patients with pancreatic cancer have locally 
unresectable disease at the time of diagnosis with limited treatment options, there is a 
growing interest in this relatively new technique8. Additionally, RF energy has also been 
used both experimentally and clinically to manage the pancreatic remnant after distal 
pancreatectomies because of its ability to seal the main and secondary pancreatic 
ducts9,10, but to our knowledge, it has not been used in other pancreatic interventions.  
In recent years, our group has tested the ability of an internally cooled RF electrode to 
seal vessels in the liver11,12 and in the kidney13. Preliminary studies using a porcine 
pancreatic model14 suggested that distal pancreatic transection by such systems can 
adequately seal the main pancreatic duct easily and safely. However, little is known 
about the use of RF ablation in the pancreas, although some studies suggest that its 
standard use is not recommended due to severe complications such as necrotizing 
pancreatitis15. 
With the above considerations in mind, our hypothesis is that, due to its ability 
to adequately seal the main pancreatic duct in the remnant pancreas, RF ablation of 
the pancreas and subsequent transection of the main pancreatic duct may avoid the 
risk of both necrotizing pancreatitis and the formation of pancreatic fistula. 
 
Materials and methods 
Animals 
A total of 39 female 6-week old Sprague-Dawley rats (Charles River 
Laboratories, Inc., Wilmington, MA, USA) were used for the study. Three rats were 
previously studied to set up the surgical approximation and were not considered in our 
analysis. The animal research protocol was approved by the Ethics Committee for 
Animal Experimentation of the PRBB (Barcelona Biomedical Research Park) and by 
the Government of Catalonia’s Animal Care Committee (FBP-10-1280 y DMAH 5452). 
 
Experimental groups  
Six groups were considered: in groups 0 to 3 (n=8, each) RF pancreatic 
ablation and subsequent section of the whole pancreas was performed at the junction 
of the duodenal and gastrosplenic portions of the pancreas (over the portal vein) 
according to the anatomic rat nomenclature described by Richard et al.16 . 
 The animals were killed at 3, 7, 15 and 21 days after the procedure, considered as 
Group 0 to 3, respectively.  Additionally, two controls group of 15 days of postoperative 
period (PO) were considered: 1) Group 4 (n=3) where animals were subjected to sham 
operation which consists on performing the surgical manipulation without ablation and 
section of the pancreas and 2) Group 5 (n=4) where animals were subjected to user 
manipulation only without any surgical procedure. This group was considered to 
evaluate possible histological changes in the proximal and distal pancreas because of 
the pancreatic dissection and manipulation. 
 
Preoperative care 
All the animals were maintained on a commercial pellet food and water ad 
libitum under controlled environmental conditions for a week to avoid the influence of 
stress. The animals were weighed and initially sedated subcutaneously with 
buprenorphine (0.001 mg/kg) 30 min before the procedure.  Anaesthetic induction was 
performed with isoflurane at 4% and maintained at 2.5% in 100% oxygen. The plantar 
and palpebral reflexes were checked previous to the surgical procedure, and breathing 
was monitored during the procedure to increase the anaesthetic dose as required. 
 
Surgical technique 
All the surgical procedures were performed by the same surgical team (R.Q and 
F.B.). Thirty-two animals (groups 0-3) underwent a pancreatic transection assisted by 
RF in the following manner. The peritoneum was entered through a midline laparotomy 
and the stomach, pancreas and spleen were mobilized. The spleen was retracted 
laterally, and the splenic vessels were dissected from the pancreatic tissue to prevent 
devascularisation of the pancreatic parenchyma. The pancreas of the experimental 
groups 0 to 3 was ablated and subsequently transected using the 3-mm version of the 
Coolinside® device (Apeiron Medical, Valencia, Spain). This device consists of a 
handheld instrument that performs a RF ablation with a cool-tip electrode of 20 mm 
length and permits section of the tissue with the built-in blade11-14. The pancreatic duct 
was not identified during the transection. The proximal and distal pancreas and the 
other viscera were replaced in anatomic position, and the incision was closed without 
abdominal drain in two layers using braided polyglycolic acid suture (4/0). The animals 
were allowed to recover from anaesthesia on an electric blanket and returned to their 
respective cages after recovering their reflexes. For control, 3 animals were subjected 
to sham operations (Group 4) in which the abdomen was opened, the internal organs 
moved, but the pancreas was not transected. Group 5 was not subjected to any 
surgical technique.  
The ablation was standardized has follows: the prove was directly placed at the 
junction of the duodenal and gastrosplenic portions of the pancreas which is placed  
over the portal vein (according to the nomenclature of rat pancreas described by 
Richard, et al.16). The pancreas was mobilized and slightly tractioned to ensure a 5-mm 
minimum safe distance between RFA site and major peripancreatic vessels and 
surrounding viscera to avoid unexpected injuries. Radiofrequency energy was applied 
by the tip of the device until a full-thickness coagulation of the pancreas at that junction 
was achieved. This coagulated tissue was subsequently sectioned in the middle of the 
RFA.  In all the procedures, ablation time, tissue impedance, current and power was 
recorded.  
 
Postoperative care and necropsy 
During PO, the animals had free access to food and water containing antibiotics 
for the firsts three days (Enrofloxacin, 500 mg/kg). Buprenorphine (0.01 mg/kg) was 
administered subcutaneously as an analgesic therapy, every 12 hours for 3 days.  
Animals were monitored for physical activity, grooming routines, level of alertness, 
response to stimulation and other signs of stress with a condition score system 
previously approved by the Welfare committee.  Serum amylase was obtained from the 
saphenous vein following the previous narcosis protocol described in all the animals 
before the initial incision and on postoperative days 3, 7, 15 and 21 as appropriate, with 
the aim of evaluating any possible sign of pancreatitis. 
At the necropsy, the animals were euthanatized by CO2 inhalation at 
100>x>70% concentration and a lateral laparotomy was carried out to explore the 
abdominal cavity. The presence of pancreatic fistula, abscess or abdominal fluid was 
recorded. Finally, the pancreas was extracted for histopathologic study. 
 
Reagents 
Polyclonal antibodies against the cleaved-caspase 3 (Asp175) and insulin 
(C27C9) were from Cell Signalling Technology (Danvers, STATE, USA).  Anti-
cytokeratin 7 antibody (RCK105) was from Santa Cruz Biotechnology (City CA, USA) 
and the secondary antibody was a avidin-biotin complex-conjugated solution of Real 
DAKO (EnVision, Copenhage, Denmark).  
 
Histopathologic study 
The distal and the proximal pancreas were fixed in 10% paraformaldehyde 
immediately after its extraction. Fixed samples were embedded in paraffin, and 
sections of 3 µm were stained with hematoxylin and eosin. Microscopic findings of 
coagulative necrosis were recorded, such as cytoplasmic shrinkage, densification and 
variable degree of chromatin condensation with focal formation of apoptotic-like bodies, 
along with the presence of abscesses to evaluate the histological changes of the 
pancreas after the surgical procedure.  The proximal pancreas was used as a control of 
normal pancreatic tissue within subjects. Group 4 (sham) and 5 (negative control) were 
used to evaluate any histological differences due to the surgical technique and 
differences between subjects, respectively.   
According to previous studies17-19 to determine the apoptotic response and the 
ductal proliferation of the pancreas, cleaved-caspase 3 (as an apoptosis marker) and 
cytokeratin 7 (as a duct cell marker) were analyzed in the most representative samples. 
Furthermore, immunohistochemical analysis of insulin was carried out in the same 
samples to evaluate the endocrine function of the distal and proximal pancreas. 
Sections (3 µm) were fixed to APS-coated glass sides, dewaxed and rehydrated. After 
antigen retrieving with sodium citrate 0.01M at, pH6 and washes with TBS x1, the 
quenching of endogenous peroxidase activity was performed using 10% H2O2 for 10 
min. The slides were then blocked in 1% BSA, 1% FBS in TBS x1 for 10 min and 
treated with primary antibody overnight at 4ºC. Primary antibodies and dilutions were 
as follows: rabbit anti-cleaved caspase 3, 1:1600; rabbit anti-insulin, 1:400 and mouse 
anti-cytokeratin 7, 1:150. After washing in TBS 1x and TBS-Tween 1x, rabbit/mouse 
secondary antibody was applied for 45 min at room temperature. 3,3’-
Diaminobenzidine (DAB) chromogen was then applied, and the slides were 
counterstained with hematoxylin.  
 
Analyzed variables 
The primary outcomes of the study were (1) postoperative complications, such 
as necrotizing pancreatitis and other perioperative parameters and (2) the histological 
changes of the pancreatic tissue after RF-assisted transection including the histological 
preservation of the endocrine distal pancreas. 
The secondary outcome of the present study was to analyze the occurrence of 
postoperative pancreatic fistulas (POPF), defined  as any  measurable volume of fluid 
on or after postoperative day 3 with an amylase content greater than 3 times the serum 
amylase activity (usually any undrained amylase-rich fluid collections/abscess). 
 
Morphometric analysis 
Computer-assisted measurements (Cell^B image acquisition, Olympus, Tokyo, 
Japan) of insulin stained islets in sections from duodenal pancreas (proximal) and 
splenic pancreas (distal) were carried out at different time points according to 
previously described methods20,21. Four to eight immunohistochemically stained insulin 
slices per specimen were used for the morphometric analysis, 5 sections were chosen 
at random from each region (proximal and distal). A total of 501 islets (with a range of 
20-83 islets from each specimen) were examined at x 100 magnification to estimate: 
(1) Profile diameter of the islet “D” calculated from  which corresponds to the major 
“a” and minor “b” diameter, respectively,20 (2) Mean hormonoreactive area “A” 
measured in µm2,21 (3) Cell count of small islets and larger islets in proximal and distal 
rat pancreas at different time points, considering an empirical distinction between small 
islets (individual beta cells and islet-clusters) with a profile area of less  than 1000 
µm2)21.  
Consecutive immunohistochemically stained cleaved-caspase 3 slices were 
used for the quantitative analysis of positive cells using ImageJ v1.43m software 
(http://rsb.info.nih.gov/ij). The analysis was performed in 5 sections choose at random 
from each region (proximal and distal). Positive cleaved-caspase 3 cells were detected 
by applying a threshold to the image, separating ground signal from background signal. 
Circular objects were defined as contiguous set of pixels applying morphological 
operations to improve the resulting object quality22,23. Quantitative data were exported 
to statistical software for further analysis.  
 
Statistical analysis 
Data are presented as median and standard deviation. Main outcomes were 
compared and correlated between groups. The Kolmogorov-Smirnov test was used to 
determine whether values followed a normal distribution and the Levene to evaluate 
equality. Mean values of numerical data were compared through the Friedman test, the 
Mann-Whitney U test, the Kruskal Wallis test or ANOVA when appropriate. Additionally, 
non-linear fits (i.e. higher order regression models) and linear regression models were 
performed in order to determine the best fit of the apoptotic response. The goodness of 
fit of a model was assessed by Pearson correlation coefficient (r), which was provided 
when any significance was detected. Differences in variables were considered to be 
significant at a threshold of p < 0.05. Statistical analyses were performed with statistical 
software (SPSS version 19.0, SPSS, Inc., Chicago, IL, USA). 
 
Results 
Survival studies and technical details 
There were no deviations from the protocol described in the methodology. 
Radiofrequency energy was applied during a mean ablation time of 89 ± 50 s at a 
mean delivered power of 20 ± 0.6 W (mean total delivered energy per ablation of 320 ± 
80 J). 
There were no major intraoperative complications or deaths. All the animals 
tolerated the procedure well and quickly recovered and ambulated. There were no 
signs of relevant disease in the postoperative follow-up, although in the immediate 
postoperative period the animals showed signs of stress and discomfort such as 
bristling hair or lack of grooming, as expected in a normal postoperative context. During 
the postoperative period the animals were active and showed no clinical symptoms of 
pancreatic disease, tolerating intake and had a growth curve with no significant 
differences other than the expected (preoperative weight 197.9 ± 19.0 g, mean pre-
necropsy weight at 3 weeks 251.6 ± 17.1 g).  
Neither undrained amylase-rich fluid collections nor abscesses were observed 
in gross examination during necropsy and no clinical anatomic evidence of pancreatic 
fistula was observed in any case.  
 
Biochemical determinations 
Figure 1 shows serum amylase before surgery and on postoperative days 3, 7, 
15 and 21. A significant increase in serum amylase levels (p<0.05) on the 3rd day PO 
over their preoperative value with no clinical repercussions was noted in groups 0-3, 
which returned to levels similar to baseline in the following weeks.  Likewise, similar 
significant differences were found in serum amylase levels on the 3rd day PO between 
groups 0-3 and groups 4 and 5 (Figure 1).  When plotted the serum amylase levels 
against their preoperative serum amylase values, 7 animals (21%) had levels above 
three times this level, but none of them presented clinical complications during the 
postoperative follow up and no intra-abdominal collections, signs of peritonitis or other 
complications were found during necropsy.  
 
Histopathological Findings 
The histopathological study distinguished between the three different areas in 
the animals subjected to radiofrequency ablation and pancreas transection: (1) the 
transection margin, (2) the proximal pancreas and (3) the distal pancreas  
1) The transection margin of the pancreatic stump was macroscopically 
characterized by a yellow dehydrated area (Figure 2) and common histological 
pattern with a central area of coagulative necrosis (Cn) surrounded by 
inflammatory infiltrate which varies in accordance with the day of necropsy. The 
ablative necrosis area at the transection margin was characterized by a mean 
maximum diameter of 5091 ± 1654 µm and a mean minimum diameter of 2434 
± 708 µm for groups 0-3. On the 3rd day, the inflammatory component was 
based on polymorphonuclear leucocytes (acute inflammation) and in some 
sections vascular congestion and slight oedema was also seen. The acute 
component decreases when the necropsy was carried out on days 15 and 21 
after transection (Groups 2 and 3) changing to a granulomatous inflammatory 
infiltrate, with macrophages and multinucleated giant cells.  Intense fibrosis was 
also present delimiting the necrotic material (see Figure 2 b).  
2) The lobular architecture of the proximal pancreas appeared unchanged in all 
the animals, with total preservation of the endocrine and exocrine tissue (see 
Figure 3 a-d). 
3)  The distal pancreas showed progressive acinar cell disappearance with 
different stages over the postoperative period. By the end of the 3rd day the total 
volume of acini appeared to be reduced, with loss of nuclear polarity and 
decreased zimogen in the cytoplasm. Apoptotic bodies were visible in most 
acinar units (see Figure 3 e). A week after the transection, there was a 
complete replacement of exocrine acini by pseudo-ductal complexes, based on 
apparently novel duct-like structures composed of low-cuboidal cells. The 
interlobular connective tissue contracted and adjacent lobules tended to 
become fused together (see Figure 3 i). On days 15 and 21 there were also 
scattered infiltrates of lymphocytes and plasma cells in the fibrous boundary. 
There also seemed to be an extension of adipose tissue surrounding the 
pancreatic tissue from the end of the 2nd week (Figures 3 m, 3 q).  
No histological changes were observed in endocrine or exocrine tissue of the 
control groups. During the histological study, no purulent inflammatory infiltrate was 
observed, but there were 3 micro-abscesses (less than 1000 µm2) in three animals; two 
cases in Group 2 and one in Group 3. No other inflammatory components were found 
in any other animals. All the animals experienced an uneventful postoperative periods.  
 
Immunohistochemical analysis  
Immunohistochemical analysis of cleaved-caspase 3 showed isolated positive 
stain in the proximal pancreas, but the distal pancreas showed a significant increase of 
acini for positive cleaved-caspase 3 staining on day 3 PO, consistent with widespread 
induction of apoptosis in this cell type at this time (see Figure 3f and Figure 5). A week 
after the transection, some acinar cells remained positive for cleaved-caspase 3 
(Figure 3 j), but in the 2nd and 3rd weeks there was little evidence of cleaved-caspase 3 
(Figure 3 n, 3 r).   
A week  after the transection, duct-like structures showed positive 
immunostaining for cytokeratine-7, which increased over the post-operatory until the 3rd 
week (see Figure 3 g, 3 k, 3 o, 3 s) while zimogen staining showed a decreased 
expression with time.  
No differences for insulin immunostaining were observed among different 
groups in the proximal pancreas. The distal pancreas showed a significant increase in 
positive insulin staining in scattered single islet cells and small islet-clusters but some 




No differences in the islet size between groups were found in the proximal 
pancreas. However, a significant decrease (p<0.05) in the mean area of the islets and 
the mean islet diameter was observed in the distal pancreas in groups 1-3 compared to 
groups 0, 4 and 5 (Table 1).  When an empirical distinction was made between small 
islets (with a profile area of less than 1000 µm2) and larger islets (over 1000 µm2), we 
found an increase of up to three times in the number of small islets in the distal 
(splenic) pancreas in groups 1-3 compared to groups 0, 4 and 5  (p<0.05) (Figure 4). 
Globally, there were significantly (p<0.05) more islets and islet-cell clusters (<1000 
µm2) in the distal pancreas of treated groups (groups 0-3) than in non-treated groups 
(groups 4-5). 
The apoptotic response was quantified by the positive expression of cleaved-
caspase 3 in the distal and proximal pancreas. No significant differences were found in 
cleaved-caspase 3 expression of the proximal pancreas over the PO, while the distal 
pancreas showed a significant positive expression at the 3rd day with a rapid decrease 
over the PO. In fact, the best-fit least square function was obtained with the inverse 




 In recent years, pancreatic surgeons have shown a growing interest in RF 
techniques. RF devices can be used in pancreatic surgery to fulfil one of two aims: 1) 
to directly ablate unresectable pancreatic tumors as a cytoreductive therapy in order to 
palliate their symptoms or even improve the survival of these patients24,25 (i.e. 
Radiofrequency ablation of pancreatic tumors) or 2) as a stump closure method 
because of its ability to seal or obliterate pancreatic ducts or small vessels in an 
attempt to avoid fistula formation usually after distal pancreatectomy9,14 (i.e. 
radiofrequency-assisted transection of the pancreas). In fact, similar devices with 
similar principles have been employed for either aim in the liver and more recently in 
the pancreas. For example, similar or identical RF cool-tip electrodes have been 
employed for either radiofrequency ablation or radiofrequency-assisted transection of 
the liver7,26  and the pancreas14,24,27,28. However, RF pancreatic ablation has been 
repeatedly warned to be associated with severe necrotizing pancreatitis with life-
threatening haemorrhagic complications, among other critical and dangerous 
complications15,27. Even though, recent experiences seem to have reduced these 
severe complications using  some prophylactic measures to avoid severe acute 
pancreatitis (such as exocrine secretion inhibition or reducing the ablative area to the 
tumor)24,28,29 or thermal damage of the duodenum (using a duodenal cooling)30, this 
technique should be considered with extreme caution because of these serious 
complications8. 
 In our study we performed RF pancreatic ablation and section of the whole 
murine pancreas at the level of the portal vein without any other measures to prevent 
acute pancreatitis and the animals were terminated at different postoperative times. To 
our knowledge this is the first time that a RF-assisted transection of the pancreas has 
been performed leaving the distal pancreas without any drainage of the main 
pancreatic duct. In the present study, all the animals tolerated the procedure well and a 
common and constant pattern with no signs of necrotizing pancreatitis or fistula 
formation was observed. Only three micro-abscesses were observed which could have 
been probably caused by a primary contamination. Similarly to other protocols of RF 
ablation of the pancreas or RF-assisted transection of the pancreas, in our study a 
temporal and clinically irrelevant increase of amylase was also described14,31. In line 
with these authors’ 14,32,33 we can speculate that this elevation could be a normal 
consequence of thermally induced coagulative necrosis and consequent cytolysis of 
the pancreatic margin, which are the first histological steps toward the formation of the 
mature fibrosis found during necropsy.  
 Our findings, in fact, are similar to an efficient ligation of the pancreatic stump. 
Ligation of the main pancreatic stump without anastomosis is actually an old technique 
of managing the remnant pancreas after PD. It was originally performed by Whipple 
and is rarely performed today mainly because of an excessive incidence of 
postoperative pancreatic fistula6 (which can reach 50 % of cases)34. The last 
prospective randomized trial of occlusion with glue of the pancreatic duct versus 
pancreaticojejunostomy after PD showed a higher fistula rate after duct occlusion (17% 
versus 5%)5. This study also suggested a possible higher risk of diabetes in occluded 
pancreatic ducts, even though it was not powered to study this variable. In fact, the low 
rate of permeability of pancreas anastomosis in clinical studies has never been linked 
to endocrine insufficiency at least in pancreatogastrostomy35,36.  
 Ultrastructural, inmunohistochemical and studies with transgenic mice have 
demonstrated that after correct experimental duct ligation, most of the acinar cells are 
rapidly and massively deleted by p53-dependent apoptosis by caspase activation with 
some pancreatic epithelial proliferation1,2,37-40 and beta-cell neogenesis by newly 
formed islet-like cell clusters21,41,42. In our study, all these histological signs were clearly 
demonstrated in the distal pancreas of RF transected pancreas in comparison to 
proximal pancreas and the pancreas of sham and control groups with appropriate 
inmunohistochemical staining.  
 As some authors have suggested, the extent of pancreatic acinar cell apoptosis 
have been shown to be inversely related to the severity of pancreatic injury, suggesting 
that induction of a rapid and massive acinar cell apoptosis is a protective action against 
acute pancreatitis42-45. Likewise, Girelli et al,25 interestingly observed that tumor-related 
obstruction of the main pancreatic duct may reduce the risk of acute pancreatitis after 
RF pancreatic ablation. Thus, the rapid and massive acinar cell deletion in our study 
after RF ablation and section of the whole pancreas may explain why this model does 
not lead to necrotizing pancreatitis.  This method could also be useful as a closure 
method of the pancreatic stump without pancreas anastomosis after PD in certain 
circumstances which could avoid the most significant cause of morbidity and mortality 
after PD. Further studies should confirm these results before its clinical application.  
 
Study limitations 
1. The murine model has been used extensively to study regeneration, 
pancreatitis and endocrine function22 but the obvious difference between the 
size of the pancreatic duct and the pancreas itself between rats and humans 
may limit the model’s applicability to pancreatic surgery.  In spite of this 
limitation, the absence of clinical and macroscopic pancreatic leakage is 
encouraging to carry out this experimental model in larger animals (which is 
actually ongoing in our laboratory). Additionally, in our model were unable to 
usually identify the main pancreatic duct in both the transection and the distal 
pancreas. Likely, the complexity and variations in the distribution of the 
pancreatic ducts (as was described by Richard, et al.16) may explain these 
findings. 
2. This study provides evidence about beta-cell neogenesis by newly formed islet-
like cell clusters in the distal pancreas after RF transection of the pancreas but 
this animal model is not useful to study the endocrine function of the distal 
remnant pancreas (because the proximal pancreas remains undamaged). 
3. In this study it was evaluated the combine effect of ablation and transection of 
the ablated pancreas. The isolated effect of either procedures is out of the 
scope of the study.  
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Figure 1. Serum amylase level at different time points.  *p<0.05 
 
Figure 2. Transection area. a) The arrow indicates the area of transection 
macroscopically, leaving to the left and right the proximal and distal margin, 
respectively. b) Transection area in the 3rd week after RF ablation and section of the 
pancreas (Group 3). Cn: Coagulative necrosis surrounded by slight fibrosis (F) and 
spared multinucleated giant cells (arrow). 
 
Figure 3. Immunohistochemical and HE staining of the proximal pancreas of Group 3 
(a-d), distal atrophic pancreas of the Group 0 (e-h), Group 1 (i-l), Group 2 (m-p) and 
Group 3 (q-t).  Line C3 notes the decrease of positive nucleus of cleaved-caspase 3 
inmunohistochemistry with the postoperatory period, while duct-like structures increase 
(CK7). Insuline immunohistochemistry (I) shows positive staining for all groups. 
 
Figure 4. Cell count of small islets (scattered and islet-cell clusters <1000 µm2) and 
larger islets among groups. Statistical analysis showed significant increase of small 
islets in the distal (splenic) pancreas in groups 1, 2 and 3 compared to groups 0, 4 and 
5. However, no significant differences were found in the proximal pancreas. *p<0.05.  
 
Figure 5. Quantitative analysis of cleaved-caspase 3 in the proximal and distal 
pancreas. The figure shows non-linear (inverse) relationship between cleaved-caspase 
3 expression of the distal pancreas and the post-operatory (Groups 0-3), while no 
significant difference is observed on the proximal pancreas. Goodness of fit of the 
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Table 1. Mean islet area (A) and mean islet diameter (D) in proximal pancreas 
(duodenal lobe) and the distal pancreas (splenic lobe). Values are mean ± SD. 
* 
Significant difference (p<0.05) between groups 1-3 and groups 0, 4, 5. 
 
                        
                      Pancreas 
Group 





Proximal 599 ± 172 517 ± 168 1371 ± 488 1061 ± 339 640 ± 164 1805 ± 558 
Distal 751 ± 252 320 ± 117* 339 ± 88* 452 ± 158* 850 ± 211 1142 ± 257 
D (µ) Proximal 69 ± 10 63 ± 10 99 ± 15 88 ± 17
 
70 ± 9 118 ± 23 




































Figure 2. Transection area. a) The arrow indicates the area of transection 
macroscopically, leaving to the left and right the proximal and distal margin, 
respectively. b) Transection area in the 3
rd
 week after RF ablation and section of the 
pancreas (Group 3). Cn: Coagulative necrosis surrounded by slight fibrosis (F) and 










Figure 3. Immunohistochemical and HE staining of the proximal pancreas of Group 3 
(a-d), distal atrophic pancreas of the Group 0 (e-h), Group 1 (i-l), Group 2 (m-p) and 
Group 3 (q-t).  Line C3 notes the decrease of positive nucleus of cleaved-caspase 3 
inmunohistochemistry with the postoperatory period, while duct-like structures increase 















Figure 4. Cell count of small islets (scattered and islet-cell clusters <1000 µm
2
) and 
larger islets among groups. Statistical analysis showed significant increase of small 
islets in the distal (splenic) pancreas in groups 1, 2 and 3 compared to groups 0, 4 and 5. 
















Figure 5. Quantitative analysis of cleaved-caspase 3 in the proximal and distal 
pancreas. The figure shows non-linear (inverse) relationship between cleaved-caspase 3 
expression of the distal pancreas and the post-operatory (Groups 0-3), while no 
significant difference is observed on the proximal pancreas. Goodness of fit of the 
model is represented by a dashed line is r=0.775 (p<0.05).  
 
 
